Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Filings indexed 1,625 across all filing types
Latest filing 2013-12-13 AGM Information
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
102年年報及股東會資料 — 2013_3164_20130624F01.pdf
AGM Information Classification · 100% confidence The document is a detailed notice and materials related to the Annual General Meeting (AGM) of 景岳生物科技股份有限公司, including the meeting date, agenda items such as reports, approvals, discussions, and proxy forms. It contains no financial statements or detailed financial analysis but focuses on the meeting logistics, agenda, and shareholder instructions. This matches the description of AGM Information (AGM-R), which includes presentations and materials shared during the AGM. The document length is about 4980 characters, which is consistent with a full AGM notice rather than a brief announcement. Therefore, the correct classification is AGM Information (AGM-R).
2013-12-13 Chinese
102年11月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, supervisors, and senior management, with specific data on stock types, quantities held at different times, and changes during the month. The content focuses on insider shareholdings and transactions, which aligns with reporting requirements for directors' dealings in company shares. There is no indication of financial statements, earnings data, or meeting materials. The document is not an announcement of a report but contains substantive data on insider shareholdings. Therefore, the most appropriate classification is Director's Dealing (DIRS).
2013-12-12 Chinese
102年11月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings of company insiders, including directors, supervisors, and executives, with specific numbers of shares held, pledged shares, and related percentages. It is a disclosure of insider shareholdings and pledges, which corresponds to reporting of personal share transactions or holdings by company directors and executives. There is no indication of financial results, meeting materials, or other report types. The document is not a general regulatory announcement or a report publication announcement. Given the content focuses on insider shareholdings and pledges, the appropriate classification is Director's Dealing (DIRS). The document length is short but contains substantive data on insider holdings, not just an announcement or certification.
2013-12-12 Chinese
102年11月營業收入
Interim / Quarterly Report Classification · 85% confidence The document is a summary report of monthly and cumulative operating revenue figures for a company named 景岳, presented in a tabular format with explanations about accounting standards and reporting practices. It contains specific financial data for a particular month and year (民國102年11月, which corresponds to November 2013). The document is short (765 characters) and focuses on revenue figures and percentage changes, without detailed financial statements or comprehensive analysis. It does not appear to be a full annual or interim report, nor an earnings release or investor presentation. It is more of a periodic financial summary report, likely an Interim / Quarterly Report (IR) because it contains substantive financial data for a period shorter than a full fiscal year. Therefore, the best classification is Interim / Quarterly Report (IR). Q4 2013
2013-12-10 Chinese
102年11月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a company named 景岳, providing information about fund loans and endorsement guarantees for the current and previous month, with amounts all zero. The content is very short (601 characters) and consists mainly of tabular data about financial guarantees and loans, without any narrative, detailed financial statements, or management discussion. It does not contain any indication of being an annual or interim report, audit report, earnings release, or other detailed filings. It appears to be a regulatory disclosure of financial status related to guarantees and loans, typical of a regulatory filing or compliance announcement. Given the short length and nature of the content, it fits best under Regulatory Filings (RNS) as a general compliance disclosure rather than a full financial report or announcement of a report.
2013-12-10 Chinese
更正公告本公司董事會決議召開102年第一次股東臨時會相關事宜
Regulatory Filings Classification · 95% confidence The document is a public announcement from a listed company regarding the correction of a board resolution to convene an extraordinary shareholders meeting (股東臨時會). It details the date and location of the meeting, agenda items including approval of restated financial reports, amendments to company bylaws, and procedural notes about share transfer suspension. The document is short (949 characters) and serves as a formal notification of meeting arrangements and agenda rather than the meeting materials or financial reports themselves. It does not contain actual financial statements or detailed financial analysis. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2013-11-25 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.